| Business Summary | | Perrigo
Company
is
the
nation's
largest
manufacturer
of
store
brand
over-the-counter
(OTC)
(non-prescription)
pharmaceutical
products
and
also
manufactures
store
brand
nutritional
products.
Store
brand
products
are
sold
under
a
retailer's
own
label
and
compete
with
nationally
advertised
brand
name
products.
These
products
include
OTC
pharmaceuticals
such
as
analgesics,
cough
and
cold
remedies,
antacids,
laxatives,
feminine
hygiene,
suppositories
and
smoking
cessation;
and
nutritional
products
such
as
synthetic
and
natural
vitamins,
herbals,
nutritional
drinks
and
diet
aids.
The
cost
to
the
customer
of
a
store
brand
product
is
significantly
lower
than
that
of
a
nationally
advertised
brand
name
product. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Perrigo
Company
is
a
manufacturer
of
store
brand
over-the-counter
pharmaceutical
products
and
also
manufactures
nutritional
products.
For
the
fiscal
year
ended
6/30/01,
net
sales
increased
1%
to
$753.5
million.
Net
income
increased
43%
to
$27.7
million.
Revenues
benefited
from
the
introduction
of
the
Company's
new
10mg
famotidine
antacid
table
and
the
acquisition
of
Wrafton
Laboratories.
Earnings
benefited
from
higher
interest
income. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Michael Jandernoa, 50 Chairman | $435K | -- | David Gibbons, 57 Pres,
CEO, Director | 949K | -- | Douglas Schrank, 52 Exec.
VP, CFO | 193K | -- | F. Folsom Bell, 58 Exec.
VP - Bus. Devel., Director | -- | -- | Mark Olesnavage, 47 Exec.
VP, Sales, Marketing and Scientific Affairs | 334K | $147K | Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|